Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Dacetuzumab> ?p ?o. }
Showing items 1 to 57 of
57
with 100 items per page.
- Dacetuzumab abstract "Dacetuzumab (also known as SGN-40 or huS2C6) is a humanized monoclonal antibody being developed for the treatment of CD40-positive cancers like non-Hodgkin's lymphoma and hematological malignancies.This drug was developed by Seattle Genetics, Inc.".
- Dacetuzumab atcPrefix "none".
- Dacetuzumab casNumber "880486-59-9".
- Dacetuzumab fdaUniiCode "UT59FF4T5X".
- Dacetuzumab wikiPageID "12597710".
- Dacetuzumab wikiPageRevisionID "585351112".
- Dacetuzumab atcPrefix "none".
- Dacetuzumab c "6452".
- Dacetuzumab casNumber "880486".
- Dacetuzumab chemspiderid "NA".
- Dacetuzumab h "9964".
- Dacetuzumab hasPhotoCollection Dacetuzumab.
- Dacetuzumab mabType "mab".
- Dacetuzumab molecularWeight "145.1".
- Dacetuzumab n "1732".
- Dacetuzumab o "1998".
- Dacetuzumab s "42".
- Dacetuzumab source "zu/o".
- Dacetuzumab synonyms "SGN-40".
- Dacetuzumab target CD40_(protein).
- Dacetuzumab type "mab".
- Dacetuzumab unii "UT59FF4T5X".
- Dacetuzumab verifiedfields "changed".
- Dacetuzumab verifiedrevid "460112574".
- Dacetuzumab subject Category:Monoclonal_antibodies_for_tumors.
- Dacetuzumab type Abstraction100002137.
- Dacetuzumab type Antibody115027189.
- Dacetuzumab type Chemical114806838.
- Dacetuzumab type Compound114818238.
- Dacetuzumab type Macromolecule114944888.
- Dacetuzumab type Material114580897.
- Dacetuzumab type Matter100020827.
- Dacetuzumab type Molecule114682133.
- Dacetuzumab type MonoclonalAntibodiesForTumors.
- Dacetuzumab type MonoclonalAntibody115029781.
- Dacetuzumab type OrganicCompound114727670.
- Dacetuzumab type Part113809207.
- Dacetuzumab type PhysicalEntity100001930.
- Dacetuzumab type Protein114728724.
- Dacetuzumab type Relation100031921.
- Dacetuzumab type Substance100019613.
- Dacetuzumab type Thing100002452.
- Dacetuzumab type Unit109465459.
- Dacetuzumab type Drug.
- Dacetuzumab type DrugProduct.
- Dacetuzumab type FunctionalSubstance.
- Dacetuzumab comment "Dacetuzumab (also known as SGN-40 or huS2C6) is a humanized monoclonal antibody being developed for the treatment of CD40-positive cancers like non-Hodgkin's lymphoma and hematological malignancies.This drug was developed by Seattle Genetics, Inc.".
- Dacetuzumab label "Dacetuzumab".
- Dacetuzumab label "Dacetuzumab".
- Dacetuzumab label "داستوزوماب".
- Dacetuzumab sameAs Dacetuzumab.
- Dacetuzumab sameAs m.02wx77c.
- Dacetuzumab sameAs Q953025.
- Dacetuzumab sameAs Q953025.
- Dacetuzumab sameAs Dacetuzumab.
- Dacetuzumab wasDerivedFrom Dacetuzumab?oldid=585351112.
- Dacetuzumab isPrimaryTopicOf Dacetuzumab.